Table 5 AUROC’s demonstrating predictive accuracy of HCC using M2BPGi, AFP, and qHBsAg.

From: Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients

Years prior to HCC diagnosis

Outcome

Factors included in prediction model

Combined M2BPGi, AFP, and qHBsAg

M2BPGi alone

AFP alone

qHBsAg alone

1–2 Years

Overall HCC

0.84

0.79

0.69

0.68

 

Cirrhotic HCC

0.92

0.86

0.73

0.75

 

Non-cirrhotic HCC

0.68

0.61

0.59

0.53

2–5 Years

Overall HCC

0.81

0.74

0.63

0.68

 

Cirrhotic HCC

0.85

0.76

0.66

0.70

 

Non-cirrhotic HCC

0.74

0.70

0.59

0.65

>5 Years

Overall HCC

0.75

0.56

0.59

0.70

 

Cirrhotic HCC

0.77

0.57

0.60

0.71

 

Non-cirrhotic HCC

0.70

0.54

0.56

0.69